Autor:	C. De Vinci, G. Corrado, F. Corrado, G. Pizza
Rok vydání:	1991
Předmět:	Oncology medicine.medical_specialty Bladder cancer business.industry Metastatic renal cancer medicine.medical_treatment Interleukin Immunotherapy medicine.disease Lymphatic system Renal cell carcinoma Internal medicine medicine Tumor regression Urological cancer business
Zdroj:	Immunotherapy of Renal Cell Carcinoma ISBN: 9783540528357
DOI:	10.1007/978-3-642-75853-9_15
Popis:	Our first published data in the immunotherapy of urological cancer with Interleukin- 2 (EL-2) date from 1984 when we observed for the first time tumor regression of infiltrating bladder cancer caused only by the intralesional injection of IL-2 [1].
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ec7f50d4d5c47357b2717539a4bf90f5 https://doi.org/10.1007/978-3-642-75853-9_15 Zobrazit plný text záznamu